Scientists at St. Jude Children's Research Hospital, the American Society for Hematology (ASH) and the Munich Leukemia ...
GLP-1 receptor agonist use may be associated with a modest increase in erectile dysfunction (ED) risk in men with type 2 ...
Last June, the FDA signaled how far that integration has progressed when it announced the use of Elsa, a generative AI tool, to support aspects of the drug approval process. While regulatory adoption ...
In the announcement, FDA Commissioner Mackary said, “Bayesian methodologies help address two of the biggest problems of drug ...
GLP-1 users are posting about side effects and symptoms not seen in clinical trials, including irregular periods, fatigue, ...
University Hospital Leipzig relies on its own AI system "LAMPE" to support doctors in real-time diagnoses and therapies.
Allogene Therapeutics, Inc. (Nasdaq: ALLO), a clinical-stage biotechnology company pioneering the development of allogeneic ...
By 2036, healthcare IT will likely be unlike anything we see today — not because of a single breakthrough technology, but because of how deeply digital tools are embedded into care delivery. Across ...
Biomedical data analysis has evolved rapidly from convolutional neural network-based systems toward transformer architectures and large-scale foundation ...
The effective participation in health information exchanges requires a focus on data governance, interoperability and ...
TriNetX, the world's leading federated health data network, today announced that it has acquired the key assets of Zetta ...
Clinical Trials Arena on MSN
UK launches programme to improve dementia clinical trial enrolment
The initiative will help clinicians find dementia patients eligible for clinical trials in the UK.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results